膀癌免疫疗法的进展:专注于静脉内疗法
Xia Tang1, Tianlun Yu2, Hongxuan Tong3
1Department of Urology, Kunshan Hospital of Traditional Chinese Medicine, Kunshan, Jiangsu, China.
Frontiers in pharmacology
|July 23, 2025
概括
新的膀癌免疫疗法,包括与Bacillus Calmette-Guérin (BCG) 和抗PD-1药物的组合,在非肌肉侵入性和肌肉侵入性膀癌中显示出改善的生存率和反应率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 目前的膀癌治疗方法Bacillus Calmette-Guérin (BCG) 有其局限性.
- 免疫疗法为膀癌提供了有希望的替代方案和组合.
研究的目的:
- 审查最近膀癌免疫治疗方面的进展.
- 突出用于非肌肉侵入性 (NMIBC) 和肌肉侵入性膀癌 (MIBC) 的新组合和药物.
主要方法:
- 对新型免疫疗法的临床试验和监管批准的审查.
- 综合疗法分析包括萨桑利马布,布罗利祖马布,纳多法拉基因,费拉登诺维克和N-803.
- 探索用于MIBC的新辅助免疫疗法和瘤性免疫疗法.
主要成果:
- 萨桑利马布与BCG的结合改善了高风险NMIBC中无事件生存率.
- 肠道抗PD-1/PD-L1药物在BCG不响应的NMIBC中显示出有效性.
- 与N-803结合的BCG实现了高的完全反应率.
- 新辅助免疫疗法和型免疫疗法在MIBC中表现有前途.
结论:
- 肠道和全身免疫疗法代表了膀癌治疗的重大进展.
- 这些新的方法显示出改善结果的潜力,需要进一步的临床研究.
相关概念视频
Tumor Immunotherapy
664
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
664
Cancer Vaccines
516
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
516


